QT Imaging to Participate in the 17th Annual Craig-Hallum Alpha Select Conference
PETALUMA, Calif.–(BUSINESS WIRE)–QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announces that it will participate in the 17th Annual Craig-Hallum Alpha Select Conference, taking place today, November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.
Members of QT Imaging’s management team will participate in one-on-one meetings with institutional investors throughout the day. Details are as follows:
|
Event: |
17th Annual Craig-Hallum Alpha Select Conference |
|
Date: |
Tuesday, November 17, 2026 |
|
Location: |
Sheraton New York Times Square Hotel, New York, NY |
|
Format: |
One-on-one investor meetings |
About QT Imaging
QT Imaging Holdings, Inc. (Nasdaq: QTI) is a medical device company engaged in the research, development, and commercialization of innovative imaging systems that use low-frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the Company’s website at www.qtimaging.com and follow us on LinkedIn.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261117531487/en/
Investors
CORE IR
Tirth Patel
[email protected]
386-295-2215
Media
CORE IR
Matthew Cossel
[email protected]
212-655-0924
KEYWORDS: United States North America California New York
INDUSTRY KEYWORDS: Research Medical Devices Health Technology Other Health Radiology Health Other Science Science Oncology
MEDIA:
